Global Stem Cell Assay Market - Global Industry Perspective, Comprehensive Analysis And Forecast, 2018 – 2025
Wiseguyreports.Com Adds “Stem Cell Assay Market -Market Demand, Growth,
Opportunities, Manufacturers, Analysis of Top Key Players and Forecast to 2025” To Its Research Database.
Description:
Global Stem
Cell Assay market was valued approximately USD 540 million in 2016, is
anticipated to grow 1580 million by 2025. The market has witnessed a
significant growth in investments from research institution and biotechnology companies
across the world. Moreover, rising prevalence of Cancer and Chronic diseases
has compelled the innovations in the market.
Assay:
Assay:
§ Cell Viability & Toxicity Assays
§ Isolation/Purification Assays
§ Cell Identification Assays
§ Cell Proliferation Assays
§ Cell Differentiation Assays
§ Cell Function Assays
§ Cell Apoptosis Assays
§ Isolation/Purification Assays
§ Cell Identification Assays
§ Cell Proliferation Assays
§ Cell Differentiation Assays
§ Cell Function Assays
§ Cell Apoptosis Assays
Kits:
§ Adult Stem Cell Kits
o Mesenchymal Stem Cell Kits
o Induced Pluripotent Stem Cell Kits
o Hematopoietic Stem Cell Kits
o Neuronal Stem Cells Kits
o Umbilical Cord Stem Cells
§ Human Embryonic Stem Cells Kits
§ Adult Stem Cell Kits
o Mesenchymal Stem Cell Kits
o Induced Pluripotent Stem Cell Kits
o Hematopoietic Stem Cell Kits
o Neuronal Stem Cells Kits
o Umbilical Cord Stem Cells
§ Human Embryonic Stem Cells Kits
Product:
§ Instruments
o Micro Electrode Arrays
o Flow Cytometer
o Cell Imaging Systems
o Automated Cell Counter
§ Detection Kits
§ Instruments
o Micro Electrode Arrays
o Flow Cytometer
o Cell Imaging Systems
o Automated Cell Counter
§ Detection Kits
Request for Sample Report@ https://www.wiseguyreports.com/sample-request/2742048-global-stem-cell-assay-market-size-study-by-assay-cell
Application:
§ Regenerative Medicine & Therapy Development
§ Drug Discovery and Development
§ Clinical Research
§ Regenerative Medicine & Therapy Development
§ Drug Discovery and Development
§ Clinical Research
Regions:
§ North America
o U.S.
o Canada
§ Europe
o UK
o Germany
o France
§ Asia Pacific
o China
o India
o Japan
§ Rest of the World
§ North America
o U.S.
o Canada
§ Europe
o UK
o Germany
o France
§ Asia Pacific
o China
o India
o Japan
§ Rest of the World
Drug discovery
and development application hold the largest share of approx. 38% in 2016.
However, regenerative medicine and therapy development application are expected
to grow at highest CAGR during the forecast period. This area of application is
expected to receive a significant amount of government and private funding in
coming years, thus expected to witness accelerated growth.
Regionally, global stem cell assay market is segmented into North America, APAC, Europe & Rest of the World (RoW). The report further provides a detailed analysis of countries under each of the mentioned regions. Globally, in 2016, North America accounted the largest revenue share of 40 %( approx) in the market. However, with rising healthcare expenditure and development of healthcare infrastructure, Asian countries are expected to witness increasing research activities in coming years. Thus, Asia Pacific stem cell assay market is expected to grow at highest CAGR during the forecast period 2017-2025.
The competitive landscape of Stem Cell Assay market is expected to soon witness rising interest of many pharmaceutical companies as well. However, currently many biotechnology companies are leading the market space. The report offers a detailed orientation of leading companies and their key strategies. Some of the key players discussed in the report include GE Healthcare, Promega Corporation, Thermo Fisher Scientific Inc., Merck KGaA, Cell Biolabs, Inc., Hemogenix Inc., STEMCELL Technologies Inc., Bio-Rad Laboratories, Inc., Bio-Techne Corporation, and Cellular Dynamics International, Inc.
Regionally, global stem cell assay market is segmented into North America, APAC, Europe & Rest of the World (RoW). The report further provides a detailed analysis of countries under each of the mentioned regions. Globally, in 2016, North America accounted the largest revenue share of 40 %( approx) in the market. However, with rising healthcare expenditure and development of healthcare infrastructure, Asian countries are expected to witness increasing research activities in coming years. Thus, Asia Pacific stem cell assay market is expected to grow at highest CAGR during the forecast period 2017-2025.
The competitive landscape of Stem Cell Assay market is expected to soon witness rising interest of many pharmaceutical companies as well. However, currently many biotechnology companies are leading the market space. The report offers a detailed orientation of leading companies and their key strategies. Some of the key players discussed in the report include GE Healthcare, Promega Corporation, Thermo Fisher Scientific Inc., Merck KGaA, Cell Biolabs, Inc., Hemogenix Inc., STEMCELL Technologies Inc., Bio-Rad Laboratories, Inc., Bio-Techne Corporation, and Cellular Dynamics International, Inc.
Complete Detail @
https://www.wiseguyreports.com/reports/2742048-global-stem-cell-assay-market-size-study-by-assay-cell
Table
of Contents
Chapter
1. Research Methodology
1.1. Research Process
1.1.1. Data Mining
1.1.2. Analysis
1.1.3. Market Estimation
1.1.4. Validation
1.1.5. Publishing
1.2. Research Assumption
1.1. Research Process
1.1.1. Data Mining
1.1.2. Analysis
1.1.3. Market Estimation
1.1.4. Validation
1.1.5. Publishing
1.2. Research Assumption
Chapter
2. Global Stem Cell Assay Market Definition & Scope
2.1. Objective of The Study
2.2. Market Definition
2.3. Scope of The Study
2.4. Years Considered for The Study
2.5. Currency Conversion Rates
2.6. Report Limitation
2.1. Objective of The Study
2.2. Market Definition
2.3. Scope of The Study
2.4. Years Considered for The Study
2.5. Currency Conversion Rates
2.6. Report Limitation
Chapter
5. Global Stem Cell Assay Market by Assay
5.1. Market Snapshot
5.2. STEM CELL ASSAY Market, Sub Segment Analysis
5.2.1. Cell Viability & Toxicity Assays
5.2.1.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
5.2.1.2. Regional breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)
5.2.2. Isolation/Purification Assays
5.2.2.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
5.2.2.2. Regional breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)
5.2.3. Cell Identification Assays
5.2.3.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
5.2.3.2. Regional breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)
5.2.4. Cell Proliferation Assays
5.2.4.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
5.2.4.2. Regional breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)
5.2.5. Cell Differentiation Assays
5.2.5.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
5.2.5.2. Regional breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)
5.2.6. Cell Function Assays
5.2.6.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
5.2.6.2. Regional breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)
5.2.7. Cell Apoptosis Assays
5.2.7.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
5.2.7.2. Regional breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)
5.1. Market Snapshot
5.2. STEM CELL ASSAY Market, Sub Segment Analysis
5.2.1. Cell Viability & Toxicity Assays
5.2.1.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
5.2.1.2. Regional breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)
5.2.2. Isolation/Purification Assays
5.2.2.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
5.2.2.2. Regional breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)
5.2.3. Cell Identification Assays
5.2.3.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
5.2.3.2. Regional breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)
5.2.4. Cell Proliferation Assays
5.2.4.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
5.2.4.2. Regional breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)
5.2.5. Cell Differentiation Assays
5.2.5.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
5.2.5.2. Regional breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)
5.2.6. Cell Function Assays
5.2.6.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
5.2.6.2. Regional breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)
5.2.7. Cell Apoptosis Assays
5.2.7.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
5.2.7.2. Regional breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)
Chapter
6. Global Stem Cell Assay Market by Kits
6.1. Market Snapshot
6.2. STEM CELL ASSAY Market, Sub Segment Analysis
6.2.1. Adult Stem Cell Kits
6.2.1.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
6.2.1.2. Regional breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)
6.2.1.2.1. Mesenchymal Stem Cell Kits
6.2.1.2.2. Induced Pluripotent Stem Cell Kits
6.2.1.2.3. Hematopoietic Stem Cell Kits
6.2.1.2.4. Neuronal Stem Cells Kits
6.2.1.2.5. Umbilical Cord Stem Cells
6.2.2. Human Embryonic Stem Cells Kits
6.2.2.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
6.2.2.2. Regional breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)
6.1. Market Snapshot
6.2. STEM CELL ASSAY Market, Sub Segment Analysis
6.2.1. Adult Stem Cell Kits
6.2.1.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
6.2.1.2. Regional breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)
6.2.1.2.1. Mesenchymal Stem Cell Kits
6.2.1.2.2. Induced Pluripotent Stem Cell Kits
6.2.1.2.3. Hematopoietic Stem Cell Kits
6.2.1.2.4. Neuronal Stem Cells Kits
6.2.1.2.5. Umbilical Cord Stem Cells
6.2.2. Human Embryonic Stem Cells Kits
6.2.2.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
6.2.2.2. Regional breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)
Continued…..
Contact
US:
NORAH
TRENT
Partner
Relations & Marketing Manager
sales@wiseguyreports.com
Ph:
+1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)
Comments
Post a Comment